Allergic rhinitis: An assessment of current pharmacotherapeutic options

Formulary

Volumn 34, Issue 12, 1999, Pages 1016-1032

  Galant, Stanley P ^a,c   Wilkinson, Robert ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST JOSEPH HOSPITAL   (United States)

^c 1201 W la Veta ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; DECONGESTIVE AGENT; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; LORATADINE; MOMETASONE FUROATE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; ARTICLE; COST; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; HUMAN; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; NOSE SEPTUM PERFORATION; ORAL DRUG ADMINISTRATION; PAIN;

EID: 0032715678     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Busse WW. Allergic rhinitis - not to be underestimated. J. Respir Dis 1998;19:S5-6.
2. Nathan RA, Melzer EO, Seiner JC, et al. Prevalence of allergic rhinitis in the US. J Allergy Clin Immunol 1997;99:5804-14.
3. Evans RE III. Epidemiology and natural history of asthma, allergic rhinitis and atopic dermatitis. In: Middleton E Jr, Reed CE, Ellis EF, et al, eds. Allergy: Principles & Practice. 4th ed. St. Louis: Mosby-Year Book; 1993:1109-36.
4. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478-518.
5. Storms W, Meltzer EO, Nathan RA, et al. The economic impact of allergic rhinitis. J Allergy Clin Immunol 1997;99:S820-4.
6. Simons FER, Reggin JO, Roberts JR, et al. Benefit/risk ratio of the antihistamine terfenadine and chlorpheniramine in children. J Pediatr 1994;124:979-83.
7. White M. Mediators of inflammation and the inflammatory process. J Allergy Clin Immunol 1999;103:S378-81.
8. Clark RR, Baroody FM. What drives the symptoms of allergic rhinitis? J Respir Dis. 1998;19:S6-15.
9. Naclerio RM. Allergic rhinitis. New Engl J Med 1991;325:860-9.
10. Gentry S. Allergic rhinitis. Always in season. Contemp Pediatr 1991;8:88-108.
11. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Allergy 1994;49(Suppl 19): 1-31.
12. 1-receptor-antagonist drugs. N Engl J Med 1994;330:1663-70.
13. Naclerio RM, Proud D, Kagey-Sobotka A, et al. The effect of cetirizine in the early allergic response. Laryngoscope 1989;99:596-9.
14. Charlesworth EN, Kagey-Sobotka A, Norman PS, et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phrase reaction. J Allergy Clin Immunol 1989;83:905-12.
15. Klementsson H, Andersson S, Pipcorn U. Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophilic influx. J Allergy Clin Immunol 1990;86:466-72.
16. McNeely W, Wiseman LR. Intranasal azelastine: Review of its efficacy in the management of allergic rhinitis. Drugs 1998;56:91-114.
17. Handley DA, Magnetti A, Higgins AJ. Therapeutic advantage of third generation antihistamines. Exp Opin Invest Drugs 1998; 7:1044-54.
18. 1 antihistamines. Ann Allergy 1991;67:625-33.
19. Sue MA, Tamasky PK, Abernathy SB, et al. A comparison of six antihistamine drugs in the treatment of perennial allergic rhinitis. Immunol Allergy Pract 1986;8:193-8.
20. Kemp JP, Bahna SL, Chervinsky P, et al. A comparison of loratadine, a new non-sedating antihistamine, with clemastine and placebo in patients with fall allergic rhinitis. Am J Rhinol 1987;1:151-4.
21. Kemp JP, Buckley CE, Gershwin ME, et al. Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann Allergy 1985;54:502-9.
22. Gengo FM, Manning C. A review of the effects of antihistamines on mental processes related to automobile driving. J Allergy Clin Immunol 1990;186:1034-9.
23. O'Hanlon JF, Ramacken JG. Antihistamine effect in actual driving performance in a standard test - a summary of the Dutch experience 1989-1994. Allergy 1995;50:234-42.
24. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action and safety of cetirizine, loratadine and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:617-26.
25. Kay JG, Plotkin KE, Quig MD, et al. Sedating effects of AM/PM antihistamine dosing with evening chlorpheniramine and morning terfenadine. Am J Manag Care 1997;3:1843-8.
26. Kemp JG. Antihistamines - is there anything safe to prescribe? Ann Allergy 1992; 69:276-80.
27. Woosley R, Dariaro WR. Analysis of potential adverse drug reaction - a case of mistaken identity. Am J Cardiol 1994;78:208-14.
28. Simons FER, Simons KJ. Second-generation Hl-receptor antagonists. Ann Allergy 1991;66:5-12.
29. Storms WW, Bodman SF, Nathan RA, et al. SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis. J Allergy CHn Immunol 1989;83:1083-90.
30. Milgrom H, Bender B. Adverse effects of medications for rhinitis. Ann Allergy Asthma Immunol 1997;78:439-46.
31. Black MJ, Remsen KA. Rhinitis medicamentosa. Can Med Assoc J 1980;122:881-3.
32. LaForce C. Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol 1999;103:S388-94.
33. Darendorf H, Hochhaus G, Meibohm B, et al. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998;101:S440-6.
34. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 1998;101:S434-9.
35. Orgel HA, Meltzer EO, Kemp JP, et al. Clinical, rhinomanometric and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous spray or pressure aerosol. J Allergy Clin Immunol 1986;72:858-64.
36. Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for treatment of perennial rhinitis. Ann Allergy Asthma Immunol 1997;79:370-8.
37. Drouin M, Yang WH, Betrand B, et al. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients. Ann Allergy Asthma Immunol 1996;77:153-60.
38. Sahay JN, Chatterjee SS, Engler C. A comparative trial of flunisolide and beclomethasone dipropionate in the treatment of perennial allergic rhinitis. Clin Allergy 1980;10:65-70.
39. Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone diproprionate in perennial rhinitis. Clin Exp Allergy 1995;25:737-43.
40. Welsh PW, Stricker WE, Chu C-P, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987;62:125-34.
41. Day J, Carrillo T. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol 1998;102:902-8.
42. Prenner BM, Chervinsky P, Ample FC, et al. Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;98:302-8.
43. Stempel DA, Thomas M. Treatment of allergic rhinitis: An evidence-based evaluation of nasal corticosteroids versus non-sedating antihistamines. Am J Manag Care 1998;4:89-96.
44. 1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 1998;317:1624-9.
45. Kaliner M, Eggleston PA, Mathews KP. Rhinitis and asthma. JAMA 1987;258:2851-73.
46. Rachelefsky GS, Chervinsky P, Meltzer EO, et al. An evaluation of the effect of BDP aqueous nasal spray on long term growth in children. J Allergy Clin Immunol 1998; 101:8236. Abstract.
47. Fraunfelder FT, Meyer SM. Posterior subcapsular cataracts associated with nasal or inhaled corticosteroids. Am J Ophthalmol 1990;109:489-90.
48. Garbe E, LeLorier J, Boivin J-F, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997;227:722-7.
49. Chandra RK, Heresig G, Woolford G. Double-blind controlled crossover trial of four percent intranasal soluble cromoglycate in patients with seasonal allergic rhinitis. Ann Allergy 1992; 49:131-4.
50. Welch PW, Yuniger JW, Kern EB, et al. Preseasonal IgE ragweed antibody level as predictor of response to treatment of ragweed hay fever with intranasal cromolyn sodium solution. J Allergy Clin Immunol 1977;60:104-6.
51. Meltzer EO, Orgel A, Bronsky E, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis. J Allergy Clin Immunol 1992;90:242-9.
52. Kaliner MA. Managing allergic rhinitis: What works? J Respir Dis 1998;19:837-46.